Search research articles
Contact Us
Filters
Showing results (501-510 of 564) with videos related to
Page
of 57
Sort By:
Clinical Pharmacology and Therapeutics
|
June 1, 1987
Pharmacokinetics of synthetic atrial natriuretic peptides in normal men
J Biollaz, L T Callahan, J Nussberger, et al.
The Journal of Clinical Investigation
|
August 1, 1987
Protection by recombinant alpha 1-antitrypsin Ala357 Arg358 against arterial hypotension induced by factor XII fragment
M Schapira, M A Ramus, B Waeber, et al.
Journal of Hypertension
|
October 11, 2001
Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout
G Würzner, J C Gerster, A Chiolero, et al.
Journal of Cardiovascular Pharmacology
|
June 1, 1995
Comparison of the oral angiotensin II receptor antagonist UP 269-6 or enalapril 20 mg on blood pressure and neurohormonal effects in salt-deplete man
M McIntyre, R J MacFadyen, P A Meredith, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1982
Evidence for a sodium-induced activation of central neurogenic mechanisms in one-kidney, one-clip renal hypertensive rats
B Waeber, H Gavras, I Gavras, et al.
Journal of Hypertension
|
April 29, 1998
Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients
A Pechère-Bertschi, J Nussberger, L Decosterd, et al.
Journal of Cardiovascular Pharmacology
|
September 1, 1991
Baroreflex and atrial natriuretic factor concentration correlate with myocardial infarct size and predict early death in rabbits: implications for drug studies
R P Hof, Y Takiguchi, J Nussberger, et al.
Lancet (London, England)
|
September 26, 1987
Are some hypertensive patients overtreated? A prospective study of ambulatory blood pressure recording
B Waeber, U Scherrer, A Petrillo, et al.
Circulation Research
|
February 1, 1975
Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changes
H Gavras, H R Brunner, J H Laragh, et al.
Clinical Science (London, England : 1979)
|
December 1, 1981
Effects of the oral angiotensin-converting enzyme inhibitor MK-421 in human hypertension
H Gavras, J Biollaz, B Waeber, et al.
Page
of 57
Search research articles
Search
Showing results (501-510 of 564) with videos related to
Sort By:
Page
of 57
Clinical Pharmacology and Therapeutics
|
June 1, 1987
Pharmacokinetics of synthetic atrial natriuretic peptides in normal men
J Biollaz, L T Callahan, J Nussberger, et al.
The Journal of Clinical Investigation
|
August 1, 1987
Protection by recombinant alpha 1-antitrypsin Ala357 Arg358 against arterial hypotension induced by factor XII fragment
M Schapira, M A Ramus, B Waeber, et al.
Journal of Hypertension
|
October 11, 2001
Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout
G Würzner, J C Gerster, A Chiolero, et al.
Journal of Cardiovascular Pharmacology
|
June 1, 1995
Comparison of the oral angiotensin II receptor antagonist UP 269-6 or enalapril 20 mg on blood pressure and neurohormonal effects in salt-deplete man
M McIntyre, R J MacFadyen, P A Meredith, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1982
Evidence for a sodium-induced activation of central neurogenic mechanisms in one-kidney, one-clip renal hypertensive rats
B Waeber, H Gavras, I Gavras, et al.
Journal of Hypertension
|
April 29, 1998
Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients
A Pechère-Bertschi, J Nussberger, L Decosterd, et al.
Journal of Cardiovascular Pharmacology
|
September 1, 1991
Baroreflex and atrial natriuretic factor concentration correlate with myocardial infarct size and predict early death in rabbits: implications for drug studies
R P Hof, Y Takiguchi, J Nussberger, et al.
Lancet (London, England)
|
September 26, 1987
Are some hypertensive patients overtreated? A prospective study of ambulatory blood pressure recording
B Waeber, U Scherrer, A Petrillo, et al.
Circulation Research
|
February 1, 1975
Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changes
H Gavras, H R Brunner, J H Laragh, et al.
Clinical Science (London, England : 1979)
|
December 1, 1981
Effects of the oral angiotensin-converting enzyme inhibitor MK-421 in human hypertension
H Gavras, J Biollaz, B Waeber, et al.
Page
of 57